3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Spondylarthritis
1
Cardiovascular Diseases
1
Arthritis, Rheumatoid
1
Interventions
sofosbuvir-velpatasvir drug combination
1
amlodipine, atorvastatin drug combination
1
acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide
1
Vitamin B 6
1
Vitamin B 12
1
Tumor Necrosis Factor Inhibitors
1
Rosuvastatin Calcium
1
Progesterone
1
Omeprazole
1
Naproxen
1
Liraglutide
1
Gonadotropin-Releasing Hormone
1
Geritol
1
Folic Acid
1
Febuxostat
1
Estradiol
1
Colchicine
1
Cholecalciferol
1
Chocolate
1
Atorvastatin
1
Antirheumatic Agents
1
Allopurinol
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Phase 4
×
Cardiovascular Diseases
×
Tumor Necrosis Factor Inhibitors
×
Clear all
NCT01548768
2020-11-27
RHYTHM
Columbia University
Phase 4
Completed
149 enrolled
15 charts